Multidrug approach fights resistance
Research results suggest that of the billions of cancer cells that exist in a patient, only about one in a million is resistant to drugs using targeted therapy.
Diagnosis & Disease Information
Varied Mutation Prevalence in Multiple Colorectal Adenomas
For patients with multiple colorectal adenomas, prevalence of APC, MUTYH mutations varies.
KRAS Mutations Predict Shorter Survival in Lung Cancer
For patients with advanced lung adenocarcinomas, KRAS mutations predict shorter survival.
Genetic variant raises glioma risk but improves survival
A rare genetic variant has been found to increase a person’s risk of developing glioma, but also cuts in half the person’s risk of death.
‘Genetic score’ may improve prostate cancer prediction
Score based on 33 single nucleotide polymorphisms is linked to prostate cancer risk.
Genetic evidence identified for role of IDO in tumorigenesis
IL-6 down, impaired myeloid-derived suppressor cells in indoleamine 2,3-dioxygenase-deficient mice.
Metastatic Colorectal Cancer and KRAS Gene Testing
Patients with metastatic colorectal cancer can use this fact sheet to learn more about personalized medicine and KRAS gene testing.
Dabrafenib shows promising results in BRAF-mutated melanoma
The drug dabrafenib significantly improved progression-free survival in persons with BRAF-mutation-positive metastatic melanoma in a phase 3 trial.
New test helps evaluate Erbitux’s merit
KRAS RGQ PCR kit checks for the presence of a certain mutation in the KRAS gene.
Sampling multiple tumor zones best to determine breast cancer metastasis
Sampling several different tumor locations and several tumor-involved lymph nodes may be necessary in order to best predict the course of breast cancer.
- Loading...
Loading...
Loading... 
Loading...